slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 60,121-60,150
Pages 2,605
Rows per page 30
Component
60,121-60,150 of 78,138
22
The chart highlights Auto Trader's significant lead over competitors like Gumtree, eBay Motors, Motors.co.uk, CarGurus, and heycar.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 1 hit
25
The chart excludes COVID-related discounts. The data is segmented by three categories: Price Lever, Stock Lever, and Product Lever.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 1 hit
26
The slide uses a stacked bar chart to show profit pools and a table to show yield percentages.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 1 hit
27
The chart uses a floating bar format to show ranges of yield percentages for different companies.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 1 hit
28
The chart uses a stacked bar approach where the solid blue represents current penetration and the hatched area represents future growth potential.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 1 hit
32
The chart uses a color shift to distinguish historical data from the forecast period.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 1 hit
35
The chart highlights the 2030 milestone for the end of new petrol and diesel car sales.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 1 hit
55
The chart highlights the significant deviation from the historical trend starting in 2020.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations Beat · Satisfaction1 hit
61
The chart highlights a clear preference for digital interaction across most tasks, while acknowledging the continued role of the physical forecourt.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 1 hit
62
Data from Auto Trader Car Buyers Tracker, July 2022, n=2,002.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 1 hit
82
The slide uses a grouped bar chart to contrast pre-pandemic and current performance metrics.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations Loop · Quick Win Big Bet1 hit
89
Uses a simple arithmetic equation structure to illustrate margin buildup.Auto Trader Group | Investor Day Presentation Deck | 100 slides · Auto Trader
Conference presentation Investor relations 1 hit
06
The slide uses a three-column structure to frame the problem: Market State, Biological Complexity, and Clinical Need.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Beat · Problem StatementLoop · Cost Of Inaction1 hit
15
The data shows a statistically significant improvement in the high-dose group at Week 24.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Beat · EvidenceLoop · Cost Of Inaction1 hit
17
Clinical trial data showing statistically significant reductions in ALT for AXA1125 groups compared to placebo.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
18
Shows statistically significant effects at week 12 for AXA1125 treatment arms.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
22
Axcella Health | Results Presentation Deck | 62 slidesAxcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
27
The slide uses a pathway diagram and a bar chart to demonstrate the mechanism of action of AXA1125 in a Primary Human Hepatocyte (PHH) Lipotoxicity Model.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
32
Includes a map-based visualization of regional prevalence and a grouped bar chart for age/sex demographics.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
34
Data source: Harrison SA et al. J Hepatol. 2021;S0168-8278:00176-8.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
36
Uses a gradient bar to illustrate the shift in risk tolerance and clinical priorities.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations Loop · Cost Of Inaction1 hit
43
The slide compares three groups (Placebo, AXA1125 22.6 BID, AXA1125 33.9 BID) across two time points (Week 12 and Week 24).Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
44
The chart compares different trial durations (24 weeks vs 72 weeks vs 18 months) and phases (Ph2b vs Ph3).Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
46
N=931. Data presented for Placebo, OCA 10mg, and OCA 25mg cohorts.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
47
The slide presents longitudinal data from the REGENERATE trial, specifically focusing on FIB-4 scores as a non-invasive test (NIT) for fibrosis.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
50
The slide uses a forest plot to visualize odds ratios and confidence intervals for clinical predictors.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
51
The slide uses a dark sidebar for context and a white main area for data presentation. It includes a citation at the bottom.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
53
Figure 3 from Stine JG, Munaganuru. Clin Gastroenterol Hepatol. 2021 Nov.Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
58
The chart compares different trial durations (24 weeks vs 72 weeks vs 18 months) and phases (Ph2b vs Ph3).Axcella Health | Results Presentation Deck | 62 slides · Axcella Therapeutics
Conference presentation Investor relations 1 hit
23
The chart uses a combination of a line graph for revenue and a vertical bar to mark a specific event (New Team Start Date).AYRO | Investor Presentation Deck | 29 slides · AYRO
Pitch deck Investor relations Beat · The Breakthrough1 hit